United Cannabis Quick Ratio (CNAB) starting from the third quarter 2019 to third quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
United Cannabis Corp  (CNAB)

United Cannabis's Quick Ratio

CNAB's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2019, Quick Ratio fell to 0.04 below United Cannabis Corp average.

Within Major Pharmaceutical Preparations industry 487 other companies have achieved higher Quick Ratio than United Cannabis in third quarter 2019. While Quick Ratio total ranking in the third quarter 2019 has deteriorated compared to the prior quarter from 4019 to 4651.

Explain Quick Ratio?
How much Cash & cash equivalents CNAB´s has?
What are CNAB´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CNAB Quick Ratio (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2		 (Mar 31 2019)
Q1		 (Dec 31 2018)
Q4		 (Sep 30 2018)
Q3
Y / Y Current Liabilities Change 376.07 % 183.78 % 552.2 % 472.2 % 214.7 %
Y / Y Cash & cash equivalent Change 105.44 % 110.8 % 172.91 % -19.51 % -57.51 %
Quick Ratio MRQ 0.04 0.12 0.07 0.1 0.1
CNAB's Total Ranking # 4651 # 4019 # 3453 # 3797 # 4193
Seq. Current Liabilities Change 46.79 % 51.7 % -11.07 % 140.4 % -12.5 %
Seq. Cash & cash equivalent Change -49.84 % 150.41 % -32.26 % 141.46 % -48.53 %



Quick Ratio third quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 488
Healthcare Sector # 928
Overall Market # 4651


Quick Ratio Statistics
High Average Low
129.87 5.84 0
(Mar 31 2014)   (Sep 30 2015)




Financial Statements
United Cannabis's Current Liabilities $ 13 Millions Visit CNAB's Balance sheet
United Cannabis's Cash & cash equivalent $ 1 Millions Visit CNAB's Balance sheet
Source of CNAB's Sales Visit CNAB's Sales by Geography


Cumulative United Cannabis's Quick Ratio

CNAB's Quick Ratio for the trailling 12 Months

CNAB Quick Ratio

 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months		 (Mar 31 2019)
12 Months		 (Dec 31 2018)
12 Months		 (Sep 30 2018)
12 Months
Y / Y Current Liabilities TTM Growth 333.99 % 297.78 % 369.39 % 244.31 % 142.12 %
Y / Y Cash & cash equivalent TTM Growth 55.92 % 15.84 % -13.71 % -21.97 % 29.71 %
Quick Ratio TTM 0.08 0.1 0.1 0.12 0.22
Total Ranking TTM # 5171 # 4890 # 2978 # 2710 # 4876
Seq. Current Liabilities TTM Growth 42.81 % 31.42 % 37.13 % 68.63 % 30.89 %
Seq. Cash & cash equivalent TTM Growth 11.53 % 30.78 % 17.4 % -8.95 % -17.14 %

Quick ratio ranking by company, industry and sector >> Back to CNAB Financial Strength Comparisons >> Go to Compare CNAB Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q3 2019 to $13.37 millions, cumulative Quick Ratio decreased to 0.08 below the United Cannabis Corp average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 479 other companies have achieved higher Quick Ratio than United Cannabis. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2019 from 4890 to 5171.

Explain Quick Ratio?
How much Cash & cash equivalents CNAB´s has?
What are CNAB´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 480
Healthcare Sector # 943
Within the Market # 5171


trailing twelve months Quick Ratio Statistics
High Average Low
1.06 0.23 0.01
(Sep 30 2014)  




Companies with similar Quick Ratio in the quarter ending Sep 30 2019, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2019 MRQ Cash & cash equivalentSep 30 2019 MRQ Current Liabilities
Q Biomed inc   0.11 $ 0.302  Millions$ 2.859  Millions
Gsk Plc  0.10 $ 6,245.718  Millions$ 61,362.490  Millions
Sunshine Biopharma Inc   0.10 $ 0.090  Millions$ 0.889  Millions
Emerald Health Therapeutics Inc.  0.10 $ 1.934  Millions$ 19.676  Millions
Skye Bioscience Inc   0.09 $ 1.324  Millions$ 13.945  Millions
Bespoke Extracts Inc  0.09 $ 0.010  Millions$ 0.111  Millions
The Greater Cannabis Company Inc   0.09 $ 0.046  Millions$ 0.500  Millions
Teva Pharmaceutical Industries Limited  0.09 $ 1,241.000  Millions$ 14,107.000  Millions
China Pharma Holdings Inc  0.08 $ 0.762  Millions$ 9.609  Millions
Cytodyn inc   0.08 $ 1.796  Millions$ 23.067  Millions
Mylan N v   0.08 $ 358.900  Millions$ 4,645.000  Millions
Earth Science Tech Inc   0.08 $ 0.058  Millions$ 0.770  Millions
Bioxytran Inc   0.05 $ 0.033  Millions$ 0.681  Millions
Wellness Center Usa Inc  0.04 $ 0.053  Millions$ 1.194  Millions
United Cannabis Corp  0.04 $ 0.565  Millions$ 13.374  Millions
Integrated Biopharma Inc  0.04 $ 0.525  Millions$ 12.542  Millions
Musclepharm Corporation  0.04 $ 1.543  Millions$ 40.238  Millions
Enveric Biosciences Inc   0.04 $ 0.500  Millions$ 13.409  Millions
Northwest Biotherapeutics Inc  0.04 $ 1.970  Millions$ 53.423  Millions
Sangui Biotech International Inc  0.03 $ 0.021  Millions$ 0.634  Millions
Tiziana Life Sciences Ltd  0.03 $ 0.200  Millions$ 7.351  Millions
Avricore Health Inc   0.02 $ 0.011  Millions$ 0.503  Millions
Actavia Life Sciences Inc   0.02 $ 0.050  Millions$ 2.406  Millions
Propanc Biopharma Inc   0.02 $ 0.096  Millions$ 4.717  Millions
Humanigen Inc  0.02 $ 0.157  Millions$ 8.524  Millions
Cardax Inc   0.02 $ 0.127  Millions$ 7.289  Millions
Gt Biopharma Inc   0.02 $ 0.313  Millions$ 18.768  Millions
Eli Lilly And Company  0.02 $ 89.200  Millions$ 5,551.600  Millions
Lifecore Biomedical Inc   0.01 $ 1.990  Millions$ 146.831  Millions
Sunwin Stevia International Inc.  0.01 $ 0.311  Millions$ 25.083  Millions

Date modified: 2026-09-12T06:21:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.